Japan Tobacco Inc.

JAPAN TOBACCO INC. NEWSROOM (1 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2019 2018 2015

Novartis: updated data from study shows significant overall survival benefit for patients with aggressive form of melanoma when treated with Tafinlar® + Mekinist®

PRESS RELEASE -- 29, September 2015

Phase III data showed median overall survival of 25.6 months in patients with BRAF+ V600E/K metastatic melanoma who received Tafinlar + Mekinist Tafinlar + Mekinist combination also demonstrated significant improvement in health-related quality of life vs vemurafenib monotherapy in this … Read the full press release